Clinical Trials
8 trialsNCT07406633 2026-05-19
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting
Kumquat Biosciences Inc.
Phase 2 Recruiting
NCT07586813 2026-05-14
N01-A-PICIT-GI
Peking University People's Hospital
Phase 2 Recruiting
NCT06096779 2026-05-04
Kirros
Genentech, Inc.
Phase 2 Recruiting
NCT06775080 2025-01-14
The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors
Huashan Hospital
Phase 2 Recruiting
NCT06099821 2023-10-26
KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 Blockade
Peking University Cancer Hospital & Institute
Phase 2 Recruiting
NCT05624099 2023-10-19
Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer.
Fujian Cancer Hospital
Phase 2 Recruiting
NCT05281003 2023-07-13
HYPERION
Fudan University
Phase 2 Recruiting
NCT05252078 2022-12-16
ALTER-E005
Jiangxi Provincial Cancer Hospital
Phase 2 Recruiting